Raymond James Financial Services Advisors’s Endologix Inc ELGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q1
Sell
-9,973
Closed -$71K 2902
2018
Q4
$71K Buy
9,973
+8,010
+408% +$89.2K ﹤0.01% 2439
2018
Q3
$37K Hold
1,963
﹤0.01% 2734
2018
Q2
$111K Hold
1,963
﹤0.01% 2600
2018
Q1
$83K Buy
1,963
+400
+26% +$17.2K ﹤0.01% 2405
2017
Q4
$84K Hold
1,563
﹤0.01% 2388
2017
Q3
$70K Hold
1,563
﹤0.01% 2429
2017
Q2
$76K Buy
1,563
+200
+15% +$11.8K ﹤0.01% 2378
2017
Q1
$99K Hold
1,363
﹤0.01% 2265
2016
Q4
$78K Buy
+1,363
New +$125K ﹤0.01% 2212

Other funds holding ELGX

Raymond James Financial Services Advisors's ELGX Position: Q1 2019 in Review

Raymond James Financial Services Advisors sold out of Endologix Inc (ELGX) in Q1 2019, closing a stake of 9,973 shares — an estimated $71K sold.

Raymond James Financial Services Advisors first reported a position in ELGX in Q4 2016 and held it in 9 quarters. The position peaked at $111K in Q2 2018. 63 funds tracked by Wall St. Rank hold ELGX as of Q1 2019.

  • Raymond James Financial Services Advisors reported no remaining Endologix Inc position as of Q1 2019 after selling out during the quarter.
  • Raymond James Financial Services Advisors sold 9,973 Endologix Inc shares in Q1 2019, an estimated $71K.
  • Raymond James Financial Services Advisors first reported a position in Endologix Inc in Q4 2016 and held it in 9 quarters.
  • Raymond James Financial Services Advisors's Endologix Inc position peaked at $111K in Q2 2018.
  • 63 funds tracked by Wall St. Rank held Endologix Inc as of Q1 2019.

Based on Raymond James Financial Services Advisors's 13F filing for Q1 2019, filed 6 May 2019.